BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 02-Jun-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 06, 2020 at 10:30 AM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

ACMELAB 29-Jan-2020

(Q2 Un-audited): EPS was Tk. 1.77 for October-December, 2019 as against Tk. 1.85 for October-December, 2018; EPS was Tk. 3.66 for July-December, 2019 as against Tk. 3.69 for July-December, 2018. NOCFPS was Tk. 1.98 for July-December, 2019 as against Tk. 4.61 for July-December, 2018. NAV per share was Tk. 86.82 as on December 31, 2019 and Tk. 86.69 as on June 30, 2019.

ACMELAB 23-Jan-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

ACMELAB 09-Jan-2020

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2019 to the respective shareholders' Bank Accounts through BEFTN. Dividend warrants of those shareholders whose Bank Accounts are not under BEFTN facilities have already been dispatched to the recorded address through courier service.

ACMELAB 23-Dec-2019

Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA-" in the long term and "ST-3 " in the short term along with a stable outlook in consideration of its audited financials up to June 30, 2019; un-audited financials up to September 30, 2019 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

ACMELAB 18-Dec-2019

Mr. Mizanur Rahman Sinha, one of the Sponsors Directors of the Company, has further reported that he has completed his buying of 1,85,000 shares of the Company at prevailing market price through Stock Exchange as per declaration disseminated on 10.12.2019.

ACMELAB 10-Dec-2019

Mr. Mizanur Rahman Sinha, one of the Sponsors Directors of the Company, has expressed his intention to buy 1,85,000 shares of the Company at prevailing market price (In the Public Market) through Stock Exchange (DSE) within next 30 working days.

ACMELAB 27-Nov-2019

Mr. Mizanur Rahman Sinha, one of the Sponsors Directors of the Company, has further reported that he has completed his buying of 1,50,000 shares of the Company at prevailing market price through Stock Exchange as per declaration disseminated on 18.11.2019.

ACMELAB 18-Nov-2019

Mr. Mizanur Rahman Sinha, one of the Sponsors Directors of the Company, has expressed his intention to buy 1,50,000 shares of the Company at prevailing market price (In the Public Market) through Stock Exchange (DSE) within next 30 working days.

ACMELAB 13-Nov-2019

(Q1 Un-audited): EPS was Tk. 1.89 for July-September 2019 as against Tk. 1.84 for July-September 2018; NOCFPS was Tk. 1.27 for July-September 2019 as against Tk. 2.35 for July-September 2018. NAV per share was Tk. 88.57 as on September 30, 2019 and Tk. 86.69 as on June 30, 2019.

Previous Next page